Open Access Government charts the Government of Canada’s policy priorities concerning arts and culture, focussing on the examples of supporting cultural space, museums and creative professionals.
The University of Iceland charts the opportunities & challenges concerning the utilisation of geothermal energy, understanding high-temperature corrosion.
Professor Dr Apichart Vanavichit, Director of the Rice Science Center, reflects on the decade since the most important gene of fragrance rice was uncovered.
Ketil Widerberg, General Manager of Oslo Cancer Cluster, describes the complexities of implementing precision cancer medicine in Norway and suggests a way forward.
Christine M. Cunningham, Professor at The Pennsylvania State University, discusses engineering solutions for children to help solve ecological problems
Philippe Mengal, Executive Director at CBE JU ‐ Circular Bio‐based Europe Joint Undertaking, charts the priorities for a strategic research & innovation agenda for competitive bio-based industries in Europe.
Phil Evans, EIDO’s Director of Partnerships, writes about the crucial importance of collaborative solutions in digital health and the healthcare sector.
Digital biomarker can identify which cases of mild cognitive impairment will develop into Alzheimer’s so that early interventions can be put in place to prevent the onset of the disease.
Joe Miller, Pocketalk General Manager of the Americas and Europe, explores how language and communication barriers affect UK government organisations & the solutions available.
Sandy Avrutin, Ocean and Earth Science Postgraduate Researcher, National Oceanography Centre at the University of Southampton, describes the uncertainty in sea-level rise, what it is & how we can use it as a tool.
Elize Sturkenboom – van de Wetering, Venture Leader of Lung Oncology at Phillips Healthcare, discusses the diagnosis and treatment of lung cancer through new minimally invasive therapy.
Optimising a drug’s ability to reach diseased body parts in adequate levels while avoiding healthy body parts – its tissue exposure and selectivity – is critical to therapeutic optimisation.
